Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...